Author

Jessica A. Mathews

University Health NetworkORCID 0000-0003-2926-8222Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:flow cytometry· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Sarah Q. CromeiD· 2 shared Abel Santos CarreiraiD· 1 shared Adrian G. SacheriD· 1 shared Albert Nguyen· 1 shared André VeilletteiD· 1 shared Arthur MorthaiD· 1 shared Carolina de Amat HerbozoiD· 1 shared Christophe PagetiD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Sarah Q. CromeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyCell ReportsPeer-reviewedDec 24, 2024

Cell therapy with IL-10-producing group 2 innate lymphoid cells suppresses Graft-versus-Host disease

Kyle T Reid, Sarah J. Colpitts, Jessica A. Mathews…·Sarah Q. Crome

This study demonstrates that IL-10-producing group 2 innate lymphoid cells (ILC210) can suppress Graft-versus-Host Disease (GVHD) in a humanized model without compromising graft-versus-leukemic effects.

14 citations

humanflow cytometry

𝕏 PostBluesky

ImmunologybioRxivPreprintJul 18, 2024

Bona fide cytotoxic iNKT cells with superior antitumour responses identified in mice and humans

Carolina de Amat Herbozo, Stephanie WY Wong, Meggie Kuypers…·Thierry Mallevaey

This study identifies specific iNKT cell subsets in mice and humans with enhanced antitumor activity, suggesting potential improvements for adoptive cell therapies.

DOI 10.1101/2024.07.18.603987

mousehuman

𝕏 PostBluesky